RaonMeta said on the 20th that it completed registrations for Korean and U.S. patents for Extended Reality (XR)-based laboratory animal dissection training content co-developed with The Catholic University of Korea Eunpyeong St. Mary's Hospital.
The laboratory animal dissection training content offered on RaonMeta's Metaverse-based training service MetaDemi was developed to allow training in a realistic environment without sacrificing actual laboratory animals. Using a virtual rat, trainees can experience the entire process from preparation to dissection to carcass disposal, and the program features a learning guide based on real dissection footage to enhance educational outcomes.
Worldwide, restrictions on animal testing are being strengthened around the "3R principle" of replacement, reduction, and refinement. In particular, in the United States, as the FDA pushes to phase out animal testing and expand the use of alternative testing methods in new drug development, including monoclonal antibody therapies, starting in 2026, demand for alternative training and simulation-based educational content is growing rapidly.
With this U.S. patent registration, RaonMeta expects rising industry interest and demand in the U.S. market for its innovative technology that can replace conventional animal dissection training, and it also expects opportunities for global expansion, including in Europe and Southeast Asia, to grow further.
Yun Won-seok, head of RaonMeta's MetaDemi Business Division, said, "Being recognized with patents in both Korea and the United States means RaonMeta's technology is competitive by global standards," and added, "Based on this patent registration, we will actively expand MetaDemi's laboratory animal dissection training content in the global medical education market."